Ascentage Pharma Group International (AAPG) Prepaid Assets (2023 - 2026)
Ascentage Pharma Group International (AAPG) posted quarterly Prepaid Assets of $4.6 million for Q4 2025, down 73.2% year-over-year from $17.2 million in Q4 2024, and down 79.46% quarter-over-quarter from $22.4 million in Q2 2025.
Analysis
Ascentage Pharma Group International (AAPG) Prepaid Assets (2023 - 2026) Analysis & Trends
Ascentage Pharma Group International's Prepaid Assets history runs 3 years deep, the most recent figure standing at $4.6 million for Q4 2025.
- In Q4 2025, Prepaid Assets fell 73.2% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (down 73.2% YoY), while the FY2025 annual figure was $4.7 million, down 72.38% from the prior year.
- Prepaid Assets for Q4 2025 stood at $4.6 million, down from $22.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $22.4 million in Q2 2025, with the low at $695131.4 in Q4 2023.
- The 3-year median for Prepaid Assets is $10.9 million (2024), against an average of $11.2 million.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 2367.58% in 2024, then slumped 73.2% in 2025.
- Ascentage Pharma Group International's Prepaid Assets stood at $695131.4 in 2023, then jumped by 2367.58% to $17.2 million in 2024, then plunged by 73.2% to $4.6 million in 2025.
- Business Quant data shows AAPG's Prepaid Assets at $4.6 million in Q4 2025, $22.4 million in Q2 2025, and $17.2 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Ascentage Pharma Group International | 1.57 Bn | 1.29 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.08 Mn |
| Dec 31, 2025 | 27.15 Mn |
| Jun 30, 2025 | 22.38 Mn |
| Dec 31, 2024 | 17.15 Mn |
| Dec 31, 2023 | 12.26 Mn |